Fischer LE, Stintzing S, von Weikersthal LF, Modest DP, et al. Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3. Br J Cancer 2022 May 30. pii: 10.1038/s41416-022-01854.
PMID: 35637412